Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

NCT02483936 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decided by Sponsor

Conditions

Arterial Hypertension

Interventions

DRUG: Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
DRUG: Olmesartan medoxomil 40mg + chlorthalidone 25mg
DRUG: Olmesartan 40mg + Hydrochlorothiazide 12,5mg
DRUG: Olmesartan 40mg + Hydrochlorothiazide 25mg

Sponsor

EMS